List of Excipients in Branded Drug FLUOCINONIDE GEL

Company	Tradename	Ingredient	NDC	Excipient	Potential Generic Entry
Alvogen Inc	FLUOCINONIDE GEL	fluocinonide gel	47781-533	CARBOMER HOMOPOLYMER TYPE C
Alvogen Inc	FLUOCINONIDE GEL	fluocinonide gel	47781-533	EDETATE DISODIUM
Alvogen Inc	FLUOCINONIDE GEL	fluocinonide gel	47781-533	PROPYL GALLATE

Generic Drugs Containing FLUOCINONIDE GEL

Company	Ingredient	NDC	Excipient
SOLA Pharmaceuticals	fluocinonide gel	70512-034	CARBOMER HOMOPOLYMER TYPE C
SOLA Pharmaceuticals	fluocinonide gel	70512-034	EDETATE DISODIUM
SOLA Pharmaceuticals	fluocinonide gel	70512-034	PROPYL GALLATE

What are the Most Frequently-Used Excipients in FLUOCINONIDE GEL?

# Of NDCs	Excipient
1	CARBOMER HOMOPOLYMER TYPE C
1	EDETATE DISODIUM
1	PROPYL GALLATE

Excipient Strategy and Commercial Opportunities for Fluocinolone Gel

Last updated: February 28, 2026

What is the role of excipients in Fluocinolone Gel formulations?

Excipients in Fluocinolone gel formulations serve multiple functions: they stabilize the active ingredient, modify viscosity, enhance skin penetration, improve shelf life, and aid in patient compliance. Common excipients include carbomers, preservatives (e.g., phenoxyethanol), humectants (e.g., glycerin), and pH adjusters (e.g., sodium hydroxide). These components influence drug stability, efficacy, and tolerability.

How does excipient selection impact product stability and bioavailability?

Excipients directly affect the stability of Fluocinolone acetonide, the active ingredient, by preventing oxidation, hydrolysis, or microbial growth. They can enhance permeation through the stratum corneum, i.e., bioavailability, by using penetration enhancers like dimethyl sulfoxide (DMSO). The optimal excipient mix ensures consistent dose delivery, minimizes irritation, and prolongs shelf life.

What commercial opportunities exist in excipient innovation?

Innovation centers around improving formulations to increase patient adherence, reduce manufacturing costs, or extend shelf life. Opportunities include:

• Development of low-irritant, hypoallergenic excipients to address sensitive skin populations.

• Use of bio-based or biodegradable excipients to meet regulatory and consumer demand for sustainability.

• Formulation of high-viscosity gels or creams with novel thickeners for better application.

• Integration of penetration enhancers in formulations to improve efficacy in difficult-to-treat dermatological conditions.

What are current regulatory considerations?

Regulatory agencies, such as the FDA and EMA, require detailed documentation of excipient safety profiles, especially for topical products. Excipients must be Generally Recognized As Safe (GRAS) and compatible with regulations for dermatological drugs. Ingredient substitution or new excipients necessitate stability testing, compatibility studies, and possibly clinical data.

What competitive advantages can excipient strategies create?

Having proprietary or optimized excipient blends can:

• Enhance shelf life and stability, extending product lifespan.
• Improve patient experience by reducing irritation or improving ease of application.
• Support fast regulatory approval with well-documented safety profiles.
• Enable formulation flexibility for combination products or new delivery systems.

How does excipient choice influence cost and supply chain?

Cost efficiency favors excipients that are globally available and easy to source. Use of common excipients like carbomers or glycerin reduces supply chain risks. Incorporating novel or specialty excipients may increase costs but could justify premium pricing through improved performance or convenience.

Summary of commercial opportunities

Opportunity	Description	Market Impact
Patient compliance improvements	Using hypoallergenic, non-irritant excipients	Increased adherence, expanded market share
Formulation innovation	Incorporating bio-based or biodegradable excipients	Regulatory approval, sustainability appeal
Enhanced stability and shelf life	Using advanced stabilizers or permeation enhancers	Reduced waste, longer shelf life
Cost optimization	Standardizing excipients for manufacturing efficiencies	Competitive pricing, higher margins

Key Takeaways

• Excipient selection in Fluocinolone gel impacts stability, efficacy, and tolerability.
• Regulatory compliance requires detailed safety and compatibility profiles.
• Innovation opportunities include hypoallergenic, sustainable, and permeation-enhancing excipients.
• Strategic excipient choices influence manufacturing costs, supply chain stability, and product differentiation.
• Formulation improvements can increase patient compliance and expand market reach.

FAQs

Q1: What are the most common excipients in Fluocinolone gel formulations?
Carbomers, preservatives like phenoxyethanol, humectants such as glycerin, and pH adjusters like sodium hydroxide.

Q2: How does excipient choice affect drug penetration?
Penetration enhancers (e.g., DMSO) or specific rheology modifiers can increase drug absorption through the skin.

Q3: Are plant-based excipients viable for Fluocinolone gels?
Yes, bio-based excipients are gaining regulatory approval and consumer interest but require thorough testing for stability and compatibility.

Q4: What barriers exist to excipient innovation?
Regulatory approval processes and extensive stability testing can slow adoption of new excipients.

Q5: How can excipient strategies support product differentiation?
By improving tolerability, stability, or sustainability, excipient choices can create unique value propositions in the competitive dermatology market.

---

References

[1] U.S. Food and Drug Administration. (2020). Guidance for Industry: Topical Drug Products.

[2] European Medicines Agency. (2022). Guideline on Stability Testing of Medicinal Products.

[3] European Pharmacopoeia. (2021). Excipients specifications and testing protocols.